Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi’s dual focus on network test platforms for 5G/Open RAN and precision optical coatings means its SEC filings pack dense technical and financial data across two very different businesses. Finding where the 10-K breaks out fiber-testing backlog, or locating anti-counterfeiting royalties hidden in footnotes, can take hours.
Stock Titan distills every document in seconds. Our AI parses each Viavi quarterly earnings report 10-Q filing, flags revenue shifts between Network Enablement and Optical Security, and answers common questions like “How much did R&D for Open RAN rise this quarter?” Real-time alerts surface Viavi insider trading Form 4 transactions the moment they hit EDGAR, while concise summaries translate 8-K material events into plain English.
Here’s what you can explore today:
- Form 4 dashboards that track Viavi executive stock transactions Form 4 alongside contract news.
- AI-annotated 10-K sections—think “Viavi annual report 10-K simplified” with direct links to segment revenue, backlog, and geographic risk.
- Interactive views of 14A data for Viavi proxy statement executive compensation, helping you compare incentive plans to 5G milestones.
- Keyword alerts for “Open RAN”, “fiber monitoring”, or “currency authentication” across every filing.
Whether you’re monitoring Viavi Form 4 insider transactions in real-time, decoding an 8-K about a new aerospace contract, or simply wanting Viavi SEC filings explained simply, our platform keeps you ahead of the market. Stop scrolling through PDFs—start understanding Viavi SEC documents with AI and make informed decisions faster.
Viavi Solutions Inc. entered into privately negotiated agreements to exchange
The company will not receive cash proceeds, because noteholders are swapping existing debt for equity. The shares issued in the exchange are expected to be offered in reliance on the Section 4(a)(2) exemption from registration under the Securities Act, based in part on representations made by the participating holders.
A director of Viavi Solutions Inc. reported selling 3,384 shares of common stock at $18.76 per share on December 10, 2025. The sale was executed under a pre-arranged Rule 10b5-1 stock trading plan dated September 10, 2025, which allows trades to follow preset instructions. After this transaction, the director beneficially owned 3,384 shares directly.
Viavi Solutions Inc. reported the results of its 2025 Annual Meeting of Stockholders held on November 12, 2025. Stockholders representing about 205.7 million shares, or roughly 92% of outstanding common stock on the record date, were present in person or by proxy. All nine director nominees received strong majority support and were elected to serve until the 2026 annual meeting.
Stockholders ratified the appointment of PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 and approved, on an advisory basis, the compensation of the company’s named executive officers. They also approved an amendment and restatement of the 2003 Equity Incentive Plan. In addition, stockholders approved amendments to the company’s Certificate of Incorporation to add an officer exculpation provision permitted under Delaware law, and the amended and restated charter became effective upon filing with the State of Delaware on November 13, 2025.
VIAVI Solutions (VIAV) reported a director equity award on a Form 4. On 11/13/2025, the reporting person received 14,369 restricted stock units (RSUs) at a price of $0, representing the right to receive the same number of shares of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes that RSUs have no expiration date. Following the transaction, the reporting person held 14,369 derivative securities directly, each underlying one share of common stock.
VIAVI Solutions (VIAV) director reported a grant of 14,369 restricted stock units (RSUs) on 11/13/2025, according to a Form 4 filing. The units vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. Following the transaction, 14,369 derivative securities were beneficially owned, with ownership reported as direct.
Viavi Solutions (VIAV) director reported an equity award of 14,369 restricted stock units (RSUs) on 11/13/2025. Each RSU is tied to one share of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs.
Following the reported transaction, the director’s beneficially owned derivative securities total 14,369, held directly.
Viavi Solutions (VIAV) filed a Form 4 reporting a director’s grant of 14,369 restricted stock units (RSUs) on 11/13/2025 at a price of $0. Following the grant, the director beneficially owns 14,369 shares directly.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The RSUs have no expiration date.
Viavi Solutions (VIAV)14,369 restricted stock units (RSUs) on November 13, 2025 at a price of $0.
The RSUs will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs have no expiration date. Following the transaction, 14,369 derivative securities are beneficially owned, reported as direct ownership. Each RSU represents a right to receive one share of common stock upon vesting.
Viavi Solutions (VIAV) reported an insider equity award. A director received 14,369 restricted stock units (RSUs) on 11/13/2025 at a stated price of $0. The RSUs are scheduled to vest on the earlier of the one-year anniversary of grant or the next Annual Meeting of Stockholders. Following the transaction, the reporting person beneficially owned 14,369 derivative securities, held directly. RSUs have no expiration date.
Viavi Solutions (VIAV) reported an insider equity award on Form 4. A director acquired 14,369 restricted stock units (RSUs) on 11/13/2025 at a reported price of $0.
The RSUs cover 14,369 shares of common stock and will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs. The position is reported as direct ownership.
FAQ
What is the current stock price of Viavi Solutions (VIAV)?
What is the market cap of Viavi Solutions (VIAV)?
